✦ LIBER ✦

Gefitinib is effective for pathological fracture of metastatic non-small cell lung cancer

✍ Scribed by Manabu Hoshi; Masatsugu Takami; Makoto Ieguchi; Kunio Takaoka

Publisher: Springer
Year: 2008
Tongue: English
Weight: 260 KB
Volume: 19
Category: Article
ISSN: 1432-1068
DOI: 10.1007/s00590-008-0406-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Establishment of a human non-small cell

Establishment of a human non-small cell lung cancer cell line resistant to gefitinib

✍ Fumiaki Koizumi; Tatsu Shimoyama; Fumiko Taguchi; Nagahiro Saijo; Kazuto Nishio 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 672 KB

## Abstract The epidermal growth factor receptor (EGFR) tyrosine‐kinase inhibitor gefitinib (Iressa®, ZD1839) has shown promising activity preclinically and clinically. Because comparative investigations of drug‐resistant sublines with their parental cells are useful approaches to identifying the m

Gefitinib in the treatment of 41 cases w

Gefitinib in the treatment of 41 cases with refractory non-small cell lung cancer

✍ Jianfang Xu; Caicun Zhou; Aiwu Li 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 76 KB

Improvements of quality of life in patie

Improvements of quality of life in patients with advanced non-small cell lung cancer treated with gefitinib

✍ Yanmei Zou; Hua Xiong; Shiying Yu 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 76 KB

Impact of functionalABCG2polymorphisms o

Impact of functionalABCG2polymorphisms on the adverse effects of gefitinib in Japanese patients with non–small-cell lung cancer

✍ Keiichi Akasaka; Takayuki Kaburagi; Shin’ichi Yasuda; Kyoko Ohmori; Kaori Abe; H 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 212 KB

Elevation of soluble interleukin-2 recep

Elevation of soluble interleukin-2 receptor in patients with non-small cell lung cancer treated with gefitinib

✍ Shigenori Kanazawa; Kazuyuki Yamaguchi; Yoshimi Kinoshita; Yutaka Komiyama; Miki 📂 Article 📅 2006 🏛 Springer-Verlag 🌐 English ⚖ 297 KB

5-fluorouracil, etoposide, and cisplatin

5-fluorouracil, etoposide, and cisplatin in the management of metastatic non-small cell lung cancer

✍ Lawrence Flaherty; Antoinette Wozniak; Bruce Redman; Michael Kraut; Silvana Mart 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 339 KB 👁 2 views